Latest News about jnj
Recent news which mentions jnj
Analyst Casts Doubts On Merus' Lung Candidate Safety Profile
October 12, 2022
From Benzinga
What 7 Analyst Ratings Have To Say About Johnson & Johnson
October 12, 2022
Tickers
JNJ
From Benzinga
From Benzinga
From Motley Fool
Prologis Passes American Tower Corp In Size By Market Cap - Becomes The Highest Valued REIT
October 10, 2022
From Benzinga
Johnson & Johnson Earnings Conference Call Is Coming Up, Here's What You Need To Know
October 10, 2022
Tickers
JNJ
From Benzinga
Get ready for a stormy earnings season with these 12 stocks from Goldman and other strategists.
October 10, 2022
From MarketWatch
This Is the Best Time to Buy These 7 Long-Term Blue-Chip Stocks
October 10, 2022
From InvestorPlace
Have $2,000? 2 Trusty Stocks to Buy Now
October 09, 2022
From Motley Fool
Here's Why 54% of My Portfolio Is in This Top Index Fund
October 08, 2022
From Motley Fool
3 Great Dividend Stocks to Buy in October
October 08, 2022
From Motley Fool
U.S. companies, including PepsiCo, accused of ‘moralwashing’ in statements about Russia
October 06, 2022
From MarketWatch
Want to Bet Against Jim Cramer? Short These 10 Stocks.
October 06, 2022
From InvestorPlace
7 Dividend Stocks That Are Too Cheap to Ignore
October 06, 2022
From InvestorPlace
3 of the Safest Dividend Stocks Retirees Can Buy Right Now
October 06, 2022
From Motley Fool
Ray Dalio Is Stepping Down. Here Are His Top 5 Stock Bets.
October 05, 2022
From InvestorPlace
US Judge Temporarily Blocks New Mexico & Mississippi Lawsuits Regarding J&J Talc: Report
October 05, 2022
Tickers
JNJ
From Benzinga
Dow Jones Bear Market: 3 Stocks to Buy Now
October 05, 2022
From Motley Fool
DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
October 04, 2022
From Benzinga
7 Recession-Proof Stocks to Buy in October
October 04, 2022
From InvestorPlace
The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint — It's Very Short
October 03, 2022
From Benzinga
Biotech Company Pleased With Results Of Early Testing Demonstrating Vaccine Potential For Multiple Sclerosis
October 03, 2022
From Benzinga
7 S&P 500 Stocks to Sell Before They Die
October 02, 2022
From InvestorPlace
Where to Invest $1,500 Right Now
October 01, 2022
From Motley Fool
2 Perfect Index Funds to Buy in a Bear Market
September 30, 2022
From Motley Fool
Why This Stock's 2.7% Dividend Yield Could Be the Safest on Wall Street
September 30, 2022
From Motley Fool
Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say
September 29, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.